Last updated: June 3, 2025
Sponsor: Boston Medical Center
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
prabotulinumtoxinA-xvfs
Clinical Study ID
NCT06903975
H-45473
Ages 18-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age eligible individual seeking a more feminine neck appearance
Exclusion
Exclusion Criteria:
Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within thepast year
Current anticoagulant use
Body mass index (BMI) >30
Anticipation of significant weight gain or loss during the study period (e.g.patients taking or planning to take within the study period a semaglutidemedication.)
Prior allergy to botulinum toxin A
Currently pregnant or breastfeeding
Study Design
Total Participants: 30
Treatment Group(s): 1
Primary Treatment: prabotulinumtoxinA-xvfs
Phase: 4
Study Start date:
May 14, 2025
Estimated Completion Date:
March 31, 2026
Study Description
Connect with a study center
The Spiegel Center
Newton, Massachusetts 02459
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.